Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
4 Patents
#1,007 in San Diego, CA
#14,051 in California
#60,641 in US
Tp Therapeutics, Inc.
Forward Citations = 82
6 inventors:
San Diego, CA, United States of America
Tp Therapeutics, Inc.
EPO Patents = 1
Trademarks = 1
Forward Citations = 82
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Jingrong Jean Cui (4 out of 45 patents)
Evan W Rogers (4 out of 47 patents)
Dayong Zhai (3 out of 22 patents)
4. Yishan Li (3 out of 10 patents)
5. Jane Ung (1 out of 19 patents)
6. Wei Deng (1 out of 14 patents)
4 patents:
Company Overview
TP Therapeutics is a precision oncology company dedicated to identifying and rapidly advancing novel targets and therapies to address unmet medical needs in cancer. Their lead candidate, TPX-0022, is a potent and selective inhibitor of MET/CSF1R/ALK. The company is committed to improving outcomes for cancer patients through innovative targeted therapies.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tp Therapeutics, Inc.. Retrieved from https://idiyas.com/company/tp-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]